Pharmacologic modulation of 5-fluorouracil by folinic acid and high-dose pyridoxine for treatment of patients with digestive tract carcinomas
Abstract Supplementation of cancer cells exposed to 5-fluorouracil (FUra) and folinic acid (FA) with high concentration pyridoxal 5′-phosphate, the cofactor of vitamin B6, potentiates the cytotoxicity of FUra in a synergistic interaction mode. We report a pilot study in 13 patients with previously u...
Main Authors: | David Machover, Wathek Almohamad, Vincent Castagné, Christophe Desterke, Léa Gomez, Yann Gaston-Mathé, Claude Boucheix, Emma Goldschmidt |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-92110-5 |
Similar Items
-
Scleroderma after 5-fluorouracil and folinic acid therapy in a patient with colon carcinoma
by: Didem Arslan TAŞ, et al.
Published: (2014-07-01) -
Adjuvant chemoradiotherapy combined with cisplatin, 5-fluorouracil and folinic acid for locally advanced gastric cancer
by: Muharrem Kocar, et al.
Published: (2016-04-01) -
Combined effects of 5-Fluorouracil, Folinic acid and Oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy
by: De Vecchis Liana, et al.
Published: (2008-05-01) -
Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment
by: Marloes Zoetemelk, et al.
Published: (2020-06-01) -
Safety and efficacy of weekly 5-fluorouracil/ folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer
by: Stefan Peinert, et al.
Published: (2010-05-01)